Clinical trial
Impact of the PRISM-care Multidisciplinary Oncology Program Versus Usual Care on Secured Drug Intake of Patients With Kidney Cancer, Through Self-management of Adverse Events Related to Oral Targeted Therapies, Control of Drug Interactions, and Sharing of the Information Between Ambulatory and Hospital Settings.
NCT02849535 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of the PRISM-care Multidisciplinary Oncology Program Versus Usual Care on Secured Drug Intake of Patients With Kidney Cancer, Through Self-management of Adverse Events Related to Oral Targeted Therapies, Control of Drug Interactions, and Sharing of the Information Between Ambulatory and Hospital Settings.
- Lead sponsor
- Hospices Civils de Lyon
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 17, 2017
- Completion date
- April 30, 2023
- Enrollment
- 190 (estimated)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
metastatic renal cell carcinoma